These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 19902646

  • 1. Chronic kidney disease in general practice: prevalence, diagnosis, and standards of care.
    Glynn LG, Anderson J, Reddan D, Murphy AW.
    Ir Med J; 2009 Oct; 102(9):285-8. PubMed ID: 19902646
    [Abstract] [Full Text] [Related]

  • 2. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 3. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA, Onuigbo NT.
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [Abstract] [Full Text] [Related]

  • 4. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 5. Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study.
    Fox CH, Swanson A, Kahn LS, Glaser K, Murray BM.
    J Am Board Fam Med; 2008 May; 21(6):522-30. PubMed ID: 18988719
    [Abstract] [Full Text] [Related]

  • 6. Facility variation in utilization of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with diabetes mellitus and chronic kidney disease.
    Tiwari A, Tseng CL, Kern EF, Maney M, Miller DR, Pogach L.
    Am J Manag Care; 2007 Feb; 13(2):73-9. PubMed ID: 17286527
    [Abstract] [Full Text] [Related]

  • 7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN.
    Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651
    [Abstract] [Full Text] [Related]

  • 8. Sympathetic hyperactivity and clinical outcome in chronic kidney disease patients during standard treatment.
    Penne EL, Neumann J, Klein IH, Oey PL, Bots ML, Blankestijn PJ.
    J Nephrol; 2009 Oct 20; 22(2):208-15. PubMed ID: 19384838
    [Abstract] [Full Text] [Related]

  • 9. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
    Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R.
    J Hypertens; 2010 Jan 20; 28(1):156-62. PubMed ID: 19915481
    [Abstract] [Full Text] [Related]

  • 10. Implementing KDOQI CKD definition and staging guidelines in Southern California Kaiser Permanente.
    Rutkowski M, Mann W, Derose S, Selevan D, Pascual N, Diesto J, Crooks P.
    Am J Kidney Dis; 2009 Mar 20; 53(3 Suppl 3):S86-99. PubMed ID: 19231766
    [Abstract] [Full Text] [Related]

  • 11. Cardiovascular risk management in chronic kidney disease in general practice (the AusHEART study).
    Razavian M, Heeley EL, Perkovic V, Zoungas S, Weekes A, Patel AA, Anderson CS, Chalmers JP, Cass A.
    Nephrol Dial Transplant; 2012 Apr 20; 27(4):1396-402. PubMed ID: 22053091
    [Abstract] [Full Text] [Related]

  • 12. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J, Małyszko J, Bachórzewska-Gajewska H, Poniatowski B, Dobrzycki S, Mysliwiec M.
    Transplant Proc; 2009 Oct 20; 41(8):3069-72. PubMed ID: 19857679
    [Abstract] [Full Text] [Related]

  • 13. Management of advanced chronic kidney disease in primary care - current data from Germany.
    Herget-Rosenthal S, Quellmann T, Linden C, Reinhardt W, Philipp T, Kribben A.
    Int J Clin Pract; 2006 Aug 20; 60(8):941-8. PubMed ID: 16780569
    [Abstract] [Full Text] [Related]

  • 14. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
    Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B.
    Am J Kidney Dis; 2008 Sep 20; 52(3):444-53. PubMed ID: 18468747
    [Abstract] [Full Text] [Related]

  • 15. Identifying patients with chronic kidney disease from general practice computer records.
    de Lusignan S, Chan T, Stevens P, O'Donoghue D, Hague N, Dzregah B, Van Vlymen J, Walker M, Hilton S.
    Fam Pract; 2005 Jun 20; 22(3):234-41. PubMed ID: 15814579
    [Abstract] [Full Text] [Related]

  • 16. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease.
    Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS.
    J Am Soc Nephrol; 2005 Aug 20; 16(8):2439-48. PubMed ID: 15930090
    [Abstract] [Full Text] [Related]

  • 17. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF, McCarthy M, Howse ML, Williams PS.
    Ren Fail; 2007 Aug 20; 29(6):653-9. PubMed ID: 17763158
    [Abstract] [Full Text] [Related]

  • 18. Reporting of estimated GFR in the primary care clinic.
    Wyatt C, Konduri V, Eng J, Rohatgi R.
    Am J Kidney Dis; 2007 May 20; 49(5):634-41. PubMed ID: 17472845
    [Abstract] [Full Text] [Related]

  • 19. [Estimation of glomerular filtration rate in primary care: prevalence of chronic kidney disease and impact on referral to nephrology].
    Lou Arnal LM, Campos Gutiérrez B, Boned Juliani B, Turón Calzada JM, Gimeno Orna JA.
    Nefrologia; 2008 May 20; 28(3):329-32. PubMed ID: 18590501
    [Abstract] [Full Text] [Related]

  • 20. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A, Goicoechea Diezhandiño M, de Alvaro Moreno F.
    Nefrologia; 2008 May 20; 28 Suppl 3():39-48. PubMed ID: 19018737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.